Kruczek, W.; Frątczak, A.; Litwińska-Inglot, I.; Polak, K.; Pawlus, Z.; Rutecka, P.; Bergler-Czop, B.; Miziołek, B.
Comparative Analysis of the Long-Term Real-World Efficacy of Interleukin-17 Inhibitors in a Cohort of Patients with Moderate-to-Severe Psoriasis Treated in Poland. J. Clin. Med. 2025, 14, 5421.
https://doi.org/10.3390/jcm14155421
AMA Style
Kruczek W, Frątczak A, Litwińska-Inglot I, Polak K, Pawlus Z, Rutecka P, Bergler-Czop B, Miziołek B.
Comparative Analysis of the Long-Term Real-World Efficacy of Interleukin-17 Inhibitors in a Cohort of Patients with Moderate-to-Severe Psoriasis Treated in Poland. Journal of Clinical Medicine. 2025; 14(15):5421.
https://doi.org/10.3390/jcm14155421
Chicago/Turabian Style
Kruczek, Wiktor, Aleksandra Frątczak, Iga Litwińska-Inglot, Karina Polak, Zuzanna Pawlus, Paulina Rutecka, Beata Bergler-Czop, and Bartosz Miziołek.
2025. "Comparative Analysis of the Long-Term Real-World Efficacy of Interleukin-17 Inhibitors in a Cohort of Patients with Moderate-to-Severe Psoriasis Treated in Poland" Journal of Clinical Medicine 14, no. 15: 5421.
https://doi.org/10.3390/jcm14155421
APA Style
Kruczek, W., Frątczak, A., Litwińska-Inglot, I., Polak, K., Pawlus, Z., Rutecka, P., Bergler-Czop, B., & Miziołek, B.
(2025). Comparative Analysis of the Long-Term Real-World Efficacy of Interleukin-17 Inhibitors in a Cohort of Patients with Moderate-to-Severe Psoriasis Treated in Poland. Journal of Clinical Medicine, 14(15), 5421.
https://doi.org/10.3390/jcm14155421
